RARE Earnings Surprises image   This RARE earnings surprises page last updated 3/11/2024
RARE Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 -1.62 -1.52 +0.10 (-6%)
Q3 2023 -2.06 -2.23 -0.17 (+8%)
Q2 2023 -2.11 -2.25 -0.14 (+7%)
Q1 2023 -1.98 -2.33 -0.35 (+18%)
Q4 2022 -2.14 -2.16 -0.02 (+1%)
Q3 2022 -1.81 -2.43 -0.62 (+34%)
Q2 2022 -1.75 -2.26 -0.51 (+29%)
Q1 2022 -1.76 -2.19 -0.43 (+24%)
Q4 2021 -1.34 -1.79 -0.45 (+34%)
Q3 2021 -1.41 -1.08 +0.33 (-23%)
Q2 2021 -1.36 -1.81 -0.45 (+33%)
Q1 2021 -1.24 -2.03 -0.79 (+64%)
Q4 2020 -1.16 -0.37 +0.79 (-68%)
Q3 2020 -1.27 -1.13 +0.14 (-11%)
Q2 2020 -1.54 -1.12 +0.42 (-27%)
Q1 2020 -1.69 -2.05 -0.36 (+21%)
Q4 2019 -1.65 -1.62 +0.03 (-2%)
Q3 2019 -1.68 -1.96 -0.28 (+17%)
Q2 2019 -1.70 -1.72 -0.02 (+1%)
Q1 2019 -1.74 -1.82 -0.08 (+5%)
Q4 2018 -1.79 -1.73 +0.06 (-3%)
Q3 2018 -1.96 -1.74 +0.22 (-11%)
Q2 2018 -2.09 -1.87 +0.22 (-11%)
Q1 2018 -0.21 -2.03 -1.82 (+867%)
Q4 2017 -1.99 -1.52 +0.47 (-24%)
Q3 2017 -1.86 -1.87 -0.01 (+1%)
Q4 2016 -1.72 -1.75 -0.03 (+2%)
Q3 2016 -1.53 -1.64 -0.11 (+7%)
RARE Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 119.38M 127.39M +8.01M (+7%)
Q3 2023 110.02M 98.05M -11.97M (-11%)
Q2 2023 105.20M 108.31M +3.11M (+3%)
Q1 2023 104.69M 100.50M -4.19M (-4%)
Q4 2022 105.12M 103.35M -1.77M (-2%)
Q3 2022 96.20M 90.70M -5.50M (-6%)
Q2 2022 87.51M 89.34M +1.83M (+2%)
Q1 2022 83.65M 79.94M -3.71M (-4%)
Q4 2021 83.79M 83.39M -0.40M (-0%)
Q3 2021 81.55M 81.65M +97000 (0%)
Q2 2021 85.03M 86.97M +1.95M (+2%)
Q1 2021 77.04M 99.39M +22.36M (+29%)
Q4 2020 70.54M 91.54M +21.00M (+30%)
Q3 2020 53.89M 81.47M +27.58M (+51%)
Q2 2020 39.12M 61.71M +22.59M (+58%)
Q1 2020 36.58M 36.31M -0.27M (-1%)
Q4 2019 32.15M 35.59M +3.44M (+11%)
Q3 2019 28.94M 25.80M -3.14M (-11%)
Q2 2019 22.52M 24.15M +1.63M (+7%)
Q1 2019 18.30M 18.17M -0.13M (-1%)
Q4 2018 14.01M 16.26M +2.25M (+16%)
Q3 2018 11.10M 11.76M +663000 (+6%)
Q2 2018 5.42M 12.79M +7.37M (+136%)
Q1 2018 52.86M 10.68M -42.18M (-80%)
Q4 2017 180000 2.41M +2.23M (-100%)
Q3 2017 20000 198000 +178000 (+890%)
Q4 2016 70000 5000 -65000 (-93%)
Q3 2016 1.16M 111000 -1.05M (+9568866%)
Quotes delayed 20 minutes

Email EnvelopeFree RARE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 3/11/2024 7:00 AM
Overseas Shipholding Gr (OSG): 3/11/2024 7:30 AM
Genie Energy (GNE): 3/11/2024 7:30 AM
Curis (CRIS): 3/11/2024 8:00 AM
Ocular Therapeutix (OCUL): 3/11/2024 After close
Ranpak Hldgs (PACK): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Assertio Holdings (ASRT): 3/11/2024 After close
Amylyx Pharma (AMLX): 3/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

Cue Biopharma (CUE): 3/9/2024 After close
Ovid Therapeutics (OVID): 3/8/2024 8:00 AM
America's Car-Mart (CRMT): 3/8/2024 8:00 AM
Sigmatron International (SGMA): 3/8/2024 8:00 AM
XOMA (XOMA): 3/8/2024 7:30 AM
Dixie Gr (DXYN): 3/8/2024 7:00 AM
Genesco (GCO): 3/8/2024 6:50 AM
Nine Energy Service (NINE): 3/7/2024 5:00 PM
Ring Energy (REI): 3/7/2024 After close
Team (TISI): 3/7/2024 After close

More from the Earnings History archive
Ultragenyx Pharmaceutical (RARE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RBOT Historical Earnings
RCEL Historical Earnings
RCKT Historical Earnings
RCUS Historical Earnings
RDNT Historical Earnings
REGN Historical Earnings
REPH Historical Earnings
REPL Historical Earnings
RETA Historical Earnings
RGEN Historical Earnings
On this page we presented the RARE earnings surprises information for Ultragenyx Pharmaceutical, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on RARE (or any other given stock) can benefit from researching all of the Ultragenyx Pharmaceutical past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Ultragenyx Pharmaceutical earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about RARE's next earnings report. In your continued research on Ultragenyx Pharmaceutical we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for RARE. Thanks for visiting, and the next time you need to research RARE earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: KYTH Options Chain, Top Ten Hedge Funds Holding IDND, SVC Insider Buying.

 

RARE Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.